Compare KLA Corp. (KLAC) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KLA Corp. vs Novartis AG — how do they compare? KLA Corp. trades at $216.78 (market cap $271.18B), while Novartis AG trades at $149.81 (market cap $290.25B). The key difference: KLA Corp. and Novartis AG are close in size by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| KLAC | NVS | |
|---|---|---|
Market Cap | $271.18B | $290.25B |
Sector | Technology | Health |
52-Week High | $301.71 | $168.62 |
52-Week Low | $84.39 | $113.50 |
Enterprise Value | $272.37B | $330.27B |
Dividend Yield | 0.44% | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
